Contribute
España
Italia
대한민국
日本
Français

Benzinga

Research
My Stocks
Tools
Free Benzinga Pro Trial
SPY
776.010.04%
QQQ
730.850.03%
BTC/USD
62892.670.2001%
DIA
536.330.09%
GLD
401.810.08%
TLT
82.04-

TuHURA Biosciences Inc

HURANASDAQ
Trade with Public
Trade with Public
$2.47
0.177.39%
At close: Aug 14, 5:00 PM EST
$2.26
-0.21-8.5%
After Hours: Aug 14, 8:02 AM EST
Earnings: Q2 2026 Earnings were released on Fri Aug 14th, before the market open
OverviewNewsEarnings ForecastEventsPrice TargetsFinancialsSentimentOwnershipCompareStock Report

TuHURA Biosciences Financials

TuHURA Biosciences (HURA) financial statements — income, revenue, gross margin and key metrics.

Earnings & Guidance News

PRO
TuHURA Biosciences Q2 EPS $(0.14) Beats $(0.15) Estimate

TuHURA Biosciences (NASDAQ:HURA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 6.67 percent. This is a 33.33 percent increase over losses of $(0.21) per share
Benzinga Newsdesk

PRO
TuHURA Biosciences Q1 EPS $(0.13) Misses $(0.12) Estimate

TuHURA Biosciences (NASDAQ:HURA) reported quarterly losses of $(0.13) per share which missed the analyst consensus estimate of $(0.12) by 8.33 percent. This is a 13.33 percent increase over losses of $(0.15) per share
Benzinga Newsdesk

PRO
TuHURA Biosciences Q4 EPS $(0.13) Beats $(0.14) Estimate

TuHURA Biosciences (NASDAQ:HURA) reported quarterly losses of $(0.13) per share which beat the analyst consensus estimate of $(0.14) by 3.7 percent. This is a 90.51 percent increase over losses of $(1.37) per share from
Benzinga Newsdesk

PRO
TuHURA Biosciences Q3 EPS $(0.14) Beats $(0.15) Estimate

TuHURA Biosciences (NASDAQ:HURA) reported quarterly losses of $(0.14) per share which beat the analyst consensus estimate of $(0.15) by 8.5 percent.
Benzinga Newsdesk

PRO
TuHURA Biosciences Q2 EPS $(0.21) Misses $(0.14) Estimate

TuHURA Biosciences (NASDAQ:HURA) reported quarterly losses of $(0.21) per share which missed the analyst consensus estimate of $(0.14) by 53.28 percent. This is a 51.16 percent increase over losses of $(0.43) per share
Benzinga Newsdesk

PRO
TuHURA Biosciences Q1 EPS $(0.15) Misses $(0.10) Estimate

TuHURA Biosciences (NASDAQ:HURA) reported quarterly losses of $(0.15) per share which missed the analyst consensus estimate of $(0.10) by 50 percent. This is a 62.5 percent increase over losses of $(0.40) per share from
Benzinga Newsdesk

Data & APIs: Benzinga APIs · Stock News API · Analyst Ratings API · Company Logo API

Connect With Us
instagramlinkedinyoutubeblueskymastodon
About Benzinga
Market Resources
Trading Tools & Education
Ring the Bell
© 2026 Benzinga | All Rights Reserved